Synthesis, Antimicrobial Activity and Molecular Docking Study of Novel N,2-Diphenylquinazolin-4-amine Derivatives Synthesis, Docking and Antimicrobial Activities of Some Quinazoline Derivatives
Iranian Journal of Pharmaceutical Sciences,
Vol. 19 No. 1 (2023),
15 January 2023
,
Page 1-10
https://doi.org/10.22037/ijps.v19i1.43111
Abstract
A new series of derivatives of N, 2-diphenylquinazolin-4-amine (3a-g) was synthesized through nucleophilic substitution. The structures of compounds were characterized by FTIR, 1H-NMR, and 13C-NMR spectroscopy. All synthesized compounds were evaluated for their antimicrobial activities against Gram-positive (Staphylococcus aureus, Bacillus subtilis, Lactobacillus rhamnosus) and Gram-negative (Escherichia coli, Pseudomonas aeruginosa) bacteria and also for antifungal activities, against Candida albicans, using broth microdilution method to determine their minimum inhibitory concentrations (MIC). Most of the compounds have shown moderate to good antibacterial activities, significantly compound 3g at 0.0625 mg/mL concentration had the highest activity against P. aeruginosa. Also, the MIC of compound 3f was 0.0078 mg/mL against S. aureus. Furthermore, the tested compounds exhibited remarkable antifungal activities against C. albicans, significantly compounds 3c and 3g showed the least MIC (equal to 0.0625 mg/mL). Also, a docking study into DNA gyrase has been made for these compounds. The synthesized compounds showed dock score values between -3.05 and -6.13kcal/mol. The highest dock score among them was -6.13 kcal/mol, found for compound 3c.
- Synthesis
- Quinazoline
- Molecular docking
- Antimicrobial activity
- DNA gyrase
- Gram-positive bacteria
- Gram-negative bacteria
How to Cite
References
Hyde j, Gorham C, Brackney D E, Steven B. Antibiotic resistant bacteria and commensal
fungi are common and conserved in the mosquito microbiome. PLoS One. (2019);1: 1-16.
Keikhosravi N, Dehghan-Ghahfarokhi E, Abdollahi S, piramoon M, Ghasemian-Yadegari J, Rezaeinasab R. J Med Chem Sci. (2022);5:308-314.
Rathod SV, Shinde KW, Kharkar PS, Shah CP. Synthesis, Molecular Docking and Biological Evaluation of New Quinoline Analogues as Potent Anti-breast Cancer and Antibacterial Agents. Iran. J. Pharm. Sci. (2020); 16(4):17-30.
Rezaeinasab R, Jafari E, Khodarahmi G. Quinazolinone based hybrids with diverse biological activities: A mini review. J Res Med Sci. (2022);27:68.
Liu G, Yang J, Su B, Liao R, Zhou W, Chen L. Design and synthesis of novel 3,4‑diaminobenzoyl derivatives as antithrombotic agents with improved solubility. Chem Pap. (2018);1: 1-8.
Rajasekaran A, Rajamanickam V, Darlinquine S. Synthesis of some new thioxoquinazolinone derivatives and a study on their anticonvulsant and antimicrobial activities. Eur Rev Med Pharmacol Sci. (2013); 17: 95-104.
Alafeefy AM, Kadi AA, Al-Deeb OA, El-Tahir KEH, Al-jaber NA. Synthesis, analgesic and anti-inflammatory evaluation of some novel quinazoline derivatives. Eur J Med Chem. (2010); 45: 4947-4952.
Zou M, Jin B, Liu Y, Chen H, Zhang Z, et al. Synthesis and Biological Evaluation of Some Novel Thiophene-bearing Quinazoline Derivatives as EGFR Inhibitors. Lett Drug Des Discov. (2019); 16: 102-110.
El‐Shershaby MH, El‐Gamal KM, Bayoumi AH, El‐Adl K, Ahmed HEA, et al. Synthesis, antimicrobial evaluation, DNA gyrase inhibition, and in silico pharmacokinetic studies of novel quinoline derivatives. Archiv der Pharmazie. (2020);1: 10-20.
Collin F, Karkare S, Maxwell A. Exploiting bacterial DNA gyrase as a drug target: current state and perspectives. Appl Microbiol Biotechnol. (2011);92(3):479-497.
Ostrov DA, Hernández Prada JA, Corsino PE, Finton KA, Le N, Rowe TC. Discovery of novel DNA gyrase inhibitors by high-throughput virtual screening. Antimicrob Agents Chemother. (2007);51(10):3688-3698.
Zhang K, Lai F, Lin F, Ji M, Zhang J, et al. Design, Synthesis and Biological Evaluation of 4-Methyl Quinazoline Derivatives as Anticancer Agents Simultaneously Targeting Phosphoinositide 3-Kinases and Histone Deacetylases. J Med Chem. (2019);1: 1-103.
An B, Wang B, Hu J, Xu S, Huang L, Li X, et al. Synthesis and Biological Evaluation of Selenium-Containing 4‑Anilinoquinazoline Derivatives as Novel Antimitotic Agents. J Med Chem. (2018); 61(6): 2571-2588.
Zheng YG, Su J, Gao CY, Jiang P, An L, Xue YS, et al. Design, synthesis, and biological evaluation of novel 4-anilinoquinazoline derivatives bearing amino acid moiety as potential EGFR kinase inhibitors. Eur J Med Chem. (2017);130: 393-405.
Thomsen R, Christensen MH. MolDock: a new technique for high-accuracy molecular docking. J Med Chem. (2006);49(11):3315-3321.
Lafitte D, Lamour V, Tsvetkov PO, Makarov AA, Klich M, Deprez P, et al. DNA gyrase interaction with coumarin-based inhibitors: the role of the hydroxybenzoate isopentenyl moiety and the 5'-methyl group of the noviose. Biochem. (2002);41(23):7217-7223.
Nasab RR, Hassanzadeh F, Khodarahmi GA, Rostami M, Mirzaei M, Jahanian-Najafabadi A, et al. Docking study, synthesis and antimicrobial evaluation of some novel 4-anilinoquinazoline derivatives. Res Pharm Sci. (2017);12(5):425-433.
Nasab RR, Mansourian M, Hassanzadeh F. Synthesis, antimicrobial evaluation and docking studies of some novel quinazolinone Schiff base derivatives. Res Pharm Sci. (2018); 13(3): 213-221.
Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK, et al. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J Comput Chem. (1998);19(14):1639-1662.
Wiegand I, Hilpert K, Hancock RE. Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc.(2008);3(2):163-175.
Baker CN, Banerjee SN, Tenover FC. Evaluation of Alamar colorimetric MIC method for antimicrobial susceptibility testing of gram-negative bacteria. J Clin Microbiol. (1994);32(5):1261-1267.
CLSI, 2015. Methods for Broth Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, 10th ed. Clinical and Lab-oratory Standards Institute. approved standardCLSI document M07-A10.
CLSI, 2012. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts: Fourth Informational Supplement, M27-S4., in: Wayne, P. (Ed.), Clinical and Laboratory Sandards Institute.
Patel AB. Investigation of the antibacterial activity of new quinazoline derivatives against methicillin and quinolone resistant Staphylococcus aureus. J Chem Res. (2020); 44(5-6): 315–321.
Kahlmeter G, Brown D, Goldstein F, Macgowan A, Mouton J, Odenholt I, Rodloff A, Soussyh CJ, Steinbakk M, Soriano F and Stetsiouk O. European committee on antimicrobial susceptibility testing (EUCAST) technical notes on antimicrobial susceptibility testing. Clin. Microbiol. Infect. (006); 12: 501-3.
Gobinath M, Subramanian N, Alagarsamy V. Design, synthesis and H1-antihistaminic activity of novel 1-substituted-4-(3-chlorophenyl)-[1,2,4]triazolo [4,3-a] quinazolin-5(4H)-ones.
J Saudi Chem Soc. (2015); 19: 282-286.
Selvam TP, Prakash CR, Saravanan G, Karthick V, Kumar PD. Synthesis of novel thiazolo-quinazolines as antinociceptive and anti-inflammatory agents. Rasayan J Chem. (2009); 2: 753-759.
Boyapati S, Kulandaivelu U, Sangu S, Vanga MR. Synthesis, Antimicrobial Evaluation, and Docking Studies of Novel 4-Substituted Quinazoline Derivatives as DNA-Gyrase Inhibitors.
Arch Pharm Chem Life Sci. (2010); 10: 570–576.
Babu KS, Yedla P, Pillai GG, Mohammad F, Reddy Ch. VR, Bhamidipati P, et al. In-silico driven design and development of spirobenzimidazo-quinazolines as potential DNA gyrase inhibitors. Biomed Pharmacother. (2021); 134:111132.
Alafeefy AM. Synthesis and Antimicrobial Activity of Some New Quinazolin-4(3H)-one Derivatives. Pharm Biol. (2008); 46: 751–756.
Rohini R, Shanker K, Reddy PM, Ravinder V. Synthesis and Antimicrobial Activities of a New Class of 6-Arylbenzimidazo[1,2-c]quinazolines. J Braz Chem Soc.( 2010); 21:49-57.
- Abstract Viewed: 105 times
- IJPS-2108-1890-Galley Proof- P. 1-10 Downloaded: 52 times